Upadacitinib for the Treatment of Upper Gastrointestinal Crohn's Disease.

IF 0.5 Q4 GASTROENTEROLOGY & HEPATOLOGY

ACG Case Reports Journal Pub Date : 2025-06-27 eCollection Date: 2025-07-01 DOI:10.14309/crj.0000000000001749

Bader AlBader, Rishi Jairath, Haneen Baitalmal, Talat Bessissow

引用次数: 0

Abstract

Data on the use of antitumor necrosis factor therapy have shown some positive outcomes in case reports or small observational studies such as the data showing the benefit of adalimumab in this rare presentation of Crohn's disease. To our knowledge, there is no published data on the use of upadacitinib in the treatment of upper gastrointestinal Crohn's disease. We present a case report of a young patient with severe oral and esophageal Crohn's disease that was successfully treated with upadacitinib.

查看原文本刊更多论文

Upadacitinib治疗上消化道克罗恩病

使用抗肿瘤坏死因子治疗的数据在病例报告或小型观察性研究中显示出一些积极的结果，例如阿达木单抗在这种罕见的克罗恩病表现中的益处。据我们所知，尚无关于upadacitinib用于治疗上消化道克罗恩病的公开数据。我们提出一个病例报告的年轻患者与严重的口腔和食道克罗恩病，成功地与upadacitinib治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACG Case Reports Journal GASTROENTEROLOGY & HEPATOLOGY-

自引率

14.30%

发文量

170

审稿时长

12 weeks

期刊介绍： ACG Case Reports Journal is a peer-reviewed, open-access publication that provides GI and hepatology fellows, private practice clinicians, and other healthcare providers an opportunity to share interesting case reports with their peers and with leaders in the field. ACG Case Reports Journal publishes case reports, images, videos and letters to the editor in all topics of gastroenterology and hepatology, including: Biliary Colon Endoscopy Esophagus Functional Bowel Disorders Inflammatory Bowel Disease Liver Nutrition and Obesity Pancreas Pathology Pediatric Small Bowel Stomach.